Mathias F. Leber

Heidelberg, BW 69120, Germany

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications

Harnessing natural RNA triplex elements found in lncRNAs MALAT1 and NEAT1 for engineering of novel riboswitch platforms.

Harnessing natural RNA triplex elements found in lncRNAs MALAT1 and NEAT1 for engineering of novel riboswitch platforms.

Journal: Nucleic acids research
Published: December 23, 2025

Celebrating Ulrik Ringborg: Multi-Omics-Based Patient Stratification for Precision Cancer Treatment.

Celebrating Ulrik Ringborg: Multi-Omics-Based Patient Stratification for Precision Cancer Treatment.

Journal: Biomolecules
Published: March 28, 2025

Oncolytic Measles Virus Encoding MicroRNA for Targeted RNA Interference.

Oncolytic Measles Virus Encoding MicroRNA for Targeted RNA Interference.

Journal: Viruses
Published: December 31, 2022

Author Correction: Cytokine release syndrome-like serum responses after COVID-19 vaccination are frequent and clinically inapparent under cancer immunotherapy.

Author Correction: Cytokine release syndrome-like serum responses after COVID-19 vaccination are frequent and clinically inapparent under cancer immunotherapy.

Journal: Nature cancer
Published: July 15, 2022

Cytokine release syndrome-like serum responses after COVID-19 vaccination are frequent and clinically inapparent under cancer immunotherapy.

Cytokine release syndrome-like serum responses after COVID-19 vaccination are frequent and clinically inapparent under cancer immunotherapy.

Journal: Nature cancer
Published: December 24, 2021

Robust envelope exchange platform for oncolytic measles virus.

Robust envelope exchange platform for oncolytic measles virus.

Journal: Journal of virological methods
Published: December 06, 2021

Virotherapy in Germany-Recent Activities in Virus Engineering, Preclinical Development, and Clinical Studies.

Virotherapy in Germany-Recent Activities in Virus Engineering, Preclinical Development, and Clinical Studies.

Journal: Viruses
Published: June 02, 2021

MicroRNA-sensitive oncolytic measles virus for chemovirotherapy of pancreatic cancer.

MicroRNA-sensitive oncolytic measles virus for chemovirotherapy of pancreatic cancer.

Journal: Molecular therapy oncolytics
Published: November 12, 2020

Engineering and combining oncolytic measles virus for cancer therapy.

Engineering and combining oncolytic measles virus for cancer therapy.

Journal: Cytokine & growth factor reviews
Published: June 15, 2020

Sequencing of serially passaged measles virus affirms its genomic stability and reveals a nonrandom distribution of consensus mutations.

Sequencing of serially passaged measles virus affirms its genomic stability and reveals a nonrandom distribution of consensus mutations.

Journal: The Journal of general virology
Published: February 14, 2020

Enhanced Control of Oncolytic Measles Virus Using MicroRNA Target Sites.

Enhanced Control of Oncolytic Measles Virus Using MicroRNA Target Sites.

Journal: Molecular therapy oncolytics
Published: February 06, 2018

Virotherapy Research in Germany: From Engineering to Translation.

Virotherapy Research in Germany: From Engineering to Translation.

Journal: Human gene therapy
Published: September 06, 2017
Showing 1-12 of 15

Last Updated: 09/26/2026